Insys Ex-CEO Babich Agrees To $30M Trustee Deal In Del.

By Jeff Montgomery · October 17, 2025, 8:26 PM EDT

Former Insys Therapeutics CEO Michael Babich has consented to a $30 million settlement amid a bankruptcy trustee's efforts to recover tens of millions in damages from company officials tied to Insys'...

To view the full article, register now.